Leptin promotes neointima formation and smooth muscle cell proliferation via NADPH oxidase activation and signalling in caveolin-rich microdomains

Cardiovascular Research

Volumn 99, Issue 3, 2013, Pages 555-565

  Schroeter, Marco R ^a   Leifheit Nestler, Maren ^a,b   Hubert, Astrid ^a   Schumann, Bettina ^a   Glückermann, Roland ^a   Eschholz, Norman ^a   Krüger, Nenja ^a   Lutz, Susanne ^a   Hasenfuss, Gerd ^a   Konstantinides, Stavros ^a,c   Schäfer, Katrin ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Apolipoprotein E; Atherosclerosis; Caveolin 1; Leptin; Neointima; Reactive oxygen species; Smooth muscle cells

Indexed keywords

APOLIPOPROTEIN E; CAVEOLIN; CAVEOLIN 1; LEPTIN; LEPTIN RECEPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; LOW DENSITY LIPOPROTEIN RECEPTOR; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CELL FRACTIONATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MALE; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR LESION; WESTERN BLOTTING; ANIMAL; ATHEROSCLEROSIS; C57BL MOUSE; CAVEOLIN-1; CELL CULTURE; CELL MEMBRANE; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SMOOTH MUSCLE CELLS; DEFICIENCY;

APOLIPOPROTEIN E; ATHEROSCLEROSIS; CAVEOLIN-1; LEPTIN; NEOINTIMA; REACTIVE OXYGEN SPECIES; SMOOTH MUSCLE CELLS;

ANIMALS; APOLIPOPROTEINS E; CAVEOLIN 1; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; LEPTIN; MALE; MEMBRANE MICRODOMAINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; NADPH OXIDASE; NEOINTIMA; REACTIVE OXYGEN SPECIES; RECEPTORS, LDL; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84886391654     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt126     Document Type: Article

References (45)

1. Schäfer K, Halle M, Goeschen C, Dellas C, Pynn M, Loskutoff DJ et al. Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol 2004;24: 112-117.
2. Bodary PF, Shen Y, Ohman M, Bahrou KL, Vargas FB, Cudney SS et al. Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance. Arterioscler Thromb Vasc Biol 2007;27:70-76.
3. Stephenson K, Tunstead J, Tsai A, Gordon R, Henderson S, Dansky HM. Neointimal formation afterendovascular arterial injury is markedly attenuated in db/db mice. Arterioscler Thromb Vasc Biol 2003;23:2027-2033.
4. Bodary PF, Gu S, Shen Y, Hasty AH, Buckler JM, Eitzman DT. Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2005;25:e119-e122.
5. Zeadin M, Butcher M, Werstuck G, Khan M, Yee CK, Shaughnessy SG. Effect of leptin on vascular calcification in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2009;29:2069-2075.
6. WuKK, WuTJ, Chin J, Mitnaul LJ, Hernandez M, CaiTQet al. Increased hypercholesterolemia and atherosclerosis in mice lacking both ApoE and leptin receptor. Atherosclerosis 2005;181:251-259.
7. Chiba T, Shinozaki S, Nakazawa T, Kawakami A, Ai M, Kaneko E et al. Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice. Atherosclerosis 2008; 196:68-75.
8. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992;71:343-353.
9. Majack RA, Castle CK, Goodman LV, Weisgraber KH, MahleyRW, Shooter EM et al. Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state. J Cell Biol 1988;107:1207-1213.
10. MooreZW, ZhuB, KuhelDG, HuiDY. Vascular apolipoprotein e expression and recruitment from circulation to modulate smooth muscle cell response to endothelial denudation. Am J Pathol 2004;164:2109-2116.
11. Ishigami M, Swertfeger DK, Granholm NA, Hui DY. Apolipoprotein E inhibits plateletderived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase. J Biol Chem 1998;273:20156-20161.
12. Zhu B, Kuhel DG, Witte DP, Hui DY. Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice. Am J Pathol 2000;157:1839-1848.
13. Huang ZH, Luque RM, Kineman RD, Mazzone T. Nutritional regulation of adipose tissue apolipoprotein E expression. Am J Physiol Endocrinol Metab 2007;293:E203-E209.
14. Shen L, Tso P, Woods SC, Clegg DJ, Barber KL, Carey K et al. Brain apolipoprotein E: an important regulator of food intake in rats. Diabetes 2008;57:2092-2098.
15. Shen L, Tso P, Wang DQ, Woods SC, Davidson WS, Sakai R et al. Up-regulation of apolipoprotein E by leptin in the hypothalamus of mice and rats. Physiol Behav 2009;98: 223-228.
16. Irani K. Oxidant signaling in vascular cell growth, death, and survival : a reviewof the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000;87:179-183.
17. Brandes RP, Schroder K. Composition and functions of vascular nicotinamide adenine dinucleotide phosphate oxidases. Trends Cardiovasc Med 2008;18:15-19.
18. Segal SS, Brett SE, SessaWC.Codistribution ofNOSand caveolin throughout peripheral vasculature and skeletal muscle of hamsters. Am J Physiol 1999;277:H1167-H1177.
19. Yen TT, Allan JA, Pearson DV, Schinitsky MR. Dissociation of obesity, hypercholesterolemia and diabetes from atherosclerosis in ob/ob mice. Experientia 1977;33:995-996.
20. Atkinson RD, Coenen KR, Plummer MR, Gruen ML, Hasty AH. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice. Am J Physiol Endocrinol Metab 2008;294:E284-E290.
21. Jun JY, Zhexi M, Pyla R, Segar L. Leptin treatment inhibits the progression of atherosclerosis by attenuating hypercholesterolemia in type 1 diabetic Ins2+/Akita:apoE-/-mice. Atherosclerosis 2012;225:341-347.
22. Oda A, Taniguchi T, Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 2001;47:141-150.
23. Barry-Lane PA, Patterson C, van der MM, Hu Z, Holland SM, Yeh ET et al. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest 2001; 108:1513-1522.
24. Chen JX, Stinnett A. Critical role of the NADPH oxidase subunit p47phox on vascular TLR expression and neointimal lesion formation in high-fat diet-induced obesity. Lab Invest 2008;88:1316-1328.
25. Touyz RM, Yao G, Schiffrin EL. c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003;23:981-987.
26. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 2002;91: 406-413.
27. Dang PM, Stensballe A, Boussetta T, Raad H, Dewas C, Kroviarski Y et al. A specific p47phox-serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites. J Clin Invest 2006;116:2033-2043.
28. Manea A, Tanase LI, Raicu M, Simionescu M. Jak/STAT signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 2010;30:105-112.
29. Kashyap VS, Santamarina-Fojo S, Brown DR, Parrott CL, Applebaum-Bowden D, Meyn S et al. Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors. J Clin Invest 1995;96:1612-1620.
30. Hasty AH, Linton MF, Brandt SJ, Babaev VR, Gleaves LA, Fazio S. Retroviral gene therapy in ApoE-deficient mice: ApoE expression in the artery wall reduces early foam cell lesion formation. Circulation 1999;99:2571-2576.
31. Ho YY, Deckelbaum RJ, Chen Y, Vogel T, Talmage DA. Apolipoprotein E inhibits serumstimulated cell proliferation and enhances serum-independent cell proliferation. J Biol Chem 2001;276:43455-43462.
32. Swertfeger DK, Hui DY. Apolipoprotein E receptor binding versus heparan sulfate proteoglycan binding in its regulation of smooth muscle cell migration and proliferation. J Biol Chem 2001;276:25043-25048.
33. Chidlow JH Jr, Sessa WC. Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. Cardiovasc Res 2010;86:219-225.
34. Peterson TE, Guicciardi ME, Gulati R, Kleppe LS, Mueske CS, Mookadam M et al. Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway. Arterioscler Thromb Vasc Biol 2003;23:1521-1527.
35. Zeidan A, Broman J, Hellstrand P, Sward K. Cholesterol dependence of vascular ERK1/2 activation and growth in response to stretch: role of endothelin-1. Arterioscler Thromb Vasc Biol 2003;23:1528-1534.
36. Singh P, Peterson TE, Sert-Kuniyoshi FH, Glenn JA, Davison DE, Romero-Corral A et al. Leptin signaling in adipose tissue: role in lipid accumulation and weight gain. Circ Res 2012; 111:599-603.
37. Huang ZH, Minshall RD, Mazzone T. Mechanism for endogenously expressed ApoE modulation of adipocyte very low density lipoprotein metabolism: role in endocytic and lipase-mediated metabolic pathways. J Biol Chem 2009;284:31512-31522.
38. Li S, Seitz R, Lisanti MP. Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J Biol Chem 1996;271:3863-3868.
39. Zuo L, Ushio-Fukai M, Ikeda S, Hilenski L, Patrushev N, AlexanderRW. Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy. Arterioscler Thromb Vasc Biol 2005;25:1824-1830.
40. Echarri A, Muriel O, PavónDM, Azegrouz H, Escolar F, TerrónMCet al. Caveolar domain organization and trafficking is regulated by Abl kinases and mDia1. J Cell Sci 2012;125: 3097-3113.
41. Zeidan A, Paylor B, Steinhoff KJ, Javadov S, Rajapurohitam V, Chakrabarti S et al. Actin cytoskeleton dynamics promotes leptin-induced vascular smooth muscle hypertrophy via RhoA/ROCK-and phosphatidylinositol 3-kinase/protein kinase B-dependent pathways. J Pharmacol Exp Ther 2007;322:1110-1116.
42. Schram K, Ganguly R, No EK, Fang X, Thong FSL, Sweeney G. Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeleton reorganization and leads to enhanced migration. Endocrinolgoy 2011;152: 2037-2047.
43. Frank PG, Lee H, Park DS, Tandon NN, Scherer PE, Lisanti MP. Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:98-105.
44. Fernandez-Hernando C, Yu J, Suarez Y, Rahner C, Davalos A, Lasuncion MA et al. Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis. Cell Metab 2009;10:48-54.
45. Jang EH, Park CS, Lee SK, Pie JE, Kang JH. Excessive nitric oxide attenuates leptinmediated signal transducer and activator of transcription 3 activation. Life Sci 2007;80: 609-617.